DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

DexCom, Inc. (DXCM) Securities Class Action: DexCom, a leading provider of continuous glucose monitoring systems, is under intense scrutiny from investors and analysts following a disappointing ...

Women’s IRFU 150-Year Anniversary Match: Ireland v Australia, Kingspan Stadium (2.30pm). URC, Round 1: Cardiff v Zebre Parma, ...

Tandem Diabetes TNDM is gaining from continued product innovations. Yet, ongoing macroeconomic challenges and tough ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Boston Scientific (BSX – Research Report), ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Medtronic (MDT – Research Report), with a ...

The t:slim X2 pump is currently cleared for use with Humalog and Novolog/NovoRapid U-100 insulins globally, and Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart Sanofi U-100 insulins in Canada ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

Check the time stamp on this data. Updated AI-Generated Signals for Dexcom Inc. (DXCM) available here: DXCM.

No pain, no gain,” that’s what Trivariate Research highlighted about stocks that have exploded nearly 1,000% over 5-year ...

After hours: September 20 at 6:39 PM EDT ...